Friday June 23rd 2017

Archive for January, 2015

Mechanisms of immunological tolerance in central nervous system inflammatory demyelination

Mechanisms of immunological tolerance in central nervous system inflammatory demyelination

Original link –  Mechanisms of immunological tolerance in central nervous system inflammatory demyelination [Read More]

Features of Hydrolysis of Specific and Nonspecific Globular Proteins and Oligopeptides by Antibodies against Viral Integrase from Blood of…

Features of Hydrolysis of Specific and Nonspecific Globular Proteins and Oligopeptides by Antibodies against Viral Integrase from Blood of…

Authors: Odintsova ES, Dmitrenok PS, Baranova SV, Timofeeva AM, Buneva VN, Nevinsky GA Abstract It was shown previously that, as differentiated from canonical proteases, abzymes against myelin basic protein (MBP) from blood of patients with multiple sclerosis and systemic [Read More]

Persistent Headache in Patients With Multiple Sclerosis Starting Treatment With Fingolimod

Persistent Headache in Patients With Multiple Sclerosis Starting Treatment With Fingolimod

(Source: Headache: The Journal of Head and Face Pain) [Read More]

 Page 1 of 110  1  2  3  4  5 » ...  Last » 

Latest Topics

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill

MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Type I interferons could have role in natural improvement of RA during pregnancy

Type I interferons could have role in natural improvement of RA during pregnancy

An international US-Danish team of scientists, led by Damini Jawaheer, Ph.D. at the UCSF Benioff Children's Hospital [Read More]

Shared decision-making essential to optimal treatment and quality of life for patients with MS

Shared decision-making essential to optimal treatment and quality of life for patients with MS

One of the cornerstones of multiple sclerosis treatment is shared decision-making between patients and their doctors [Read More]

UC consortium formed to speed up development of new drugs

UC consortium formed to speed up development of new drugs

For 12 years, UCLA researcher Dennis Slamon pursued a groundbreaking approach to treating breast cancer: Attack the [Read More]